High Prevalence of High-Risk Human Papillomavirus Genotypes Other Than Hpv-16 and Hpv-18 in Congolese Women Living With HIV: Implication for Cervical Cancer Prevention in a Resource Limited Setting

Abstract

Background: Despite the undeniable benefits provided by antiretroviral therapy (ART) in drastically reducing AIDS-related mortality, women living with HIV (WLWH) are disproportionately affected by high-risk Human Papillomavirus (HR-HPV) infection and cervical cancer. We herein assessed the distribution of HR-HPV genotypes according to HIV immunovirological prognostic parameters and their implications for the prevention of cervical cancer.